Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 5, 2005 - Issue 5
Submit an article Journal homepage
180
Views
18
CrossRef citations to date
0
Altmetric
Review

Cutaneous malignant melanoma: facts about sunbeds and sunscreen

Philippe Autier Jules Bordet Institute, Unit of Epidemiology, Prevention and Screening, Bd of Waterloo 121, Brussels 1000, Belgium. [email protected]
Pages 821-833 | Published online: 10 Jan 2014

References

  • International Agency for Research on Cancer Expert Group. Solar and Ultraviolet Radiation. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 55. IARC Scientific Publications, Lyon, France (1992).
  • International Agency for Research on Cancer. Sunscreens In: Handbooks in Cancer Chemoprevention. Volume 5. IARC Scientific Publications, Lyon, France (2001).
  • Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch. Dermatol. 131, 170–175 (1995).
  • Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N. Engl. J. Med. 329, 1147–1151 (1993).
  • Green A, Williams G, Neale R et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354, 723–729 (1999).
  • Autier P, Dore JF, Schifflers E et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Co-operative Group. Int. J. Cancer 61, 749–755 (1995).
  • Westerdahl J, Olsson H, Masback A et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 5, 59–65 (1995).
  • Westerdahl J, Ingvar C, Masback A et al. Sunscreen use and malignant melanoma. Int. J. Cancer 87, 145–150 (2000).
  • Autier P, Doré JF, Renard F et al. Melanoma and sunscreen use: need for studies representative of actual behaviours. Melanoma Res. 7(Suppl. 2), S115–S120 (1997).
  • Wolf P, Donawho CK, Kripke ML et al. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J. Natl Cancer Inst. 86, 99–105 (1994).
  • Gandini S, Sera F, Cattaruza MS et al. Meta-analysis of risk factors for cutaneous melanoma: I common and atypical naevi. Eur. J. Cancer 41, 28–44 (2005).
  • Autier P, Doré JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. Int. J. Cancer 77, 533–537 (1998).
  • Whiteman DC, Whiteman CA, Green A et al. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12, 69–82 (2001).
  • Autier P, Doré JF, Cattaruzza MS et al. for the EORTC Melanoma Group. Sunscreen use, wearing clothes and nevi number in 6- to 7-year-old European children. J. Natl Cancer Inst. 90, 1873–1881(1998).
  • Luther H, Altmeyer P, Garbe C et al. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch. Dermatol.132 (12), 1473–1478 (1996).
  • Dulon M, Weichenthal M, Blettner M et al. Sun exposure and number of nevi in 5-to-6-year-old European children. J. Clin. Epidemiol. 55, 1075–1081 (2002).
  • Bauer J, Buttner P, Wiecker TS et al. Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care. Am. J. Epidemiol. 161, 620–627 (2005).
  • Wachsmuth RC, Turner F, Barret JH et al. The effect of sun exposure in determining nevus density in UK adolescent twins. J. Invest. Dermatol. 124, 56–62 (2005).
  • Azizi E, Iscovich J, Pvlostsky F et al. Use of sunscreen is linked with elevated naevi counts in Israeli school children and adolescents. Mel. Res. 10, 491–498 (2000).
  • Darlington S, Siskind V, Green L et al. Longitudinal study of melanocytic nevi in adolescents. J. Am. Acad. Dermatol. 46, 715–722 (2002).
  • Whiteman DC, Brown RM, Purdie DM et al. Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. J. Am. Acad. Dermatol. 52, 40–47 (2005).
  • Harrison SL, Buettner PG, McLennan R et al. The North Queensland ‘Sun-sage clothing’ Study: design and baseline results of a randomized trial to determine the effectiveness of sun-protective clothing in preventing melanocytic nevi. Am. J. Epidemiol. 161, 536–545 (2005).
  • Huncharek M, Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. Am. Eur. J. Public Health92, 1173–1177 (2002).
  • Dennis KL, Beane Freeman LE, VanBeek MJ et al. Sunscreen use and the risk for melanoma: a quantitative review. Ann. Intern. Med. 139, 966–978 (2003).
  • Elwood JM, Gallagher RP. More about: sunscreen use, wearing clothes, and number of nevi in 6-to7-year-old European children. J. Natl Cancer Inst. 13, 1164–1165 (1999).
  • Gefeller O, Pfahlberg A. Susncreen use and melanoma: a case of evidence-based prevention? Photodermatol. Photoimmunol. Photomed. 18, 153–156 (2002).
  • Espinosa Arranz J, Sanchez Hernandez JJ, Bravo Fernandez P et al. Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res. 9, 199–205 (1999).
  • Rodenas JM, Delgado-Rodriguez M, Herranz MT et al. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 7, 275–283 (1996).
  • Wolf P, Quehenberger F, Mullegger R et al. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res. 8, 370–378 (1998).
  • Holly EA, Aston DA, Cress RD et al. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am. J. Epidemiol. 141, 923–933 (1995).
  • Gallagher RP, Rivers JK, Lee TK et al. Broad spectrum sunscreen use and the development of new nevi in white children. JAMA 283, 2955–2960 (2000).
  • Bauer J, Buttner P, Wiecker TS et al. Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behaviour. Int. J. Cancer (2005) (In Press).
  • Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow-up measurements. Br. Med. J. 323, 1123–1124 (2001).
  • Barnett AG, van der Pols JC, Dobson AJ et al. Regression to the mean: what it is and how to deal with it. Int. J. Epidemiol. 34, 215–220 (2005).
  • English DR, Milen E, Jacoby P et al. The effect of a school-based sun protection intervention on the development of melanocytic nevi in children: 6-year follow-up. Cancer Epidemiol. Biom. Prev. 14, 977–980 (2005).
  • Severi G, Cattaruzza MS, Baglietto L et al. Sun exposure and sun protection in young European children. an EORTC multicentric study. Eur. J. Cancer 38, 820–826 (2002).
  • Holman CD, Armstrong BK, Heenan PJ et al. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J. Natl Cancer Inst. 76, 403–414 (1986).
  • Beitner H, Norell SE, Ringborg U et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br. J. Dermatol. 122, 43–51 (1990).
  • Wulf, HC, Stender IM, Lock-Andersen J et al. Sunscreens used at the beach do not protect against erythema: a new definition of SPF is proposed. Photodermatol. Photoimmunol. Photomed. 13, 129–132(1997).
  • McCarthy EM, Ethridge KP, Wagner RF et al. Beach holiday sunburn: the sunscreen paradox and gender differences. Cutis 64, 37–42 (1999).
  • Berwick M, Fine JA, Bolognia JL et al. Sun exposure and sunscreen use following a community skin cancer screening. Prev. Med. 21, 302–310 (1992).
  • Robinson JK, Rigell DS, Amonette RA et al. Summertime sun protection used by adults for their children. J. Am. Acad. Dermatol. 42, 746–753 (2000).
  • Garbe C, Buettner PG. Predictors of the use of sunscreen in dermatological patients in Central Europe. Prev. Med. 312, 134–139 (2000).
  • Autier P, Doré JF, Négrier S et al. Sunscreen use and duration of sun exposure: A double-blind randomized trial. J. Natl Cancer Inst. 15, 1304–1309 (1999).
  • Autier P, Doré JF, Conde Reis A et al. Sunscreen use and recreational exposure to ultraviolet A and B radiation: A double-blind randomized trial using personal dosimeters. Br. J. Cancer 83, 1243–1248 (2000).
  • Green A, Williams G, Neale R et al. Betacarotene and sunscreen use: author’s reply. Lancet 354, 2164 (1999).
  • Hill D, White V, Marks R et al. Melanoma prevention: behavioral and non-behavioral factors in sunburn among an Australian population. Prev. Med. 21, 654–669 (1992).
  • Hill D, White V, Marks R et al. Changes in sun-related attitudes and behaviors, and reduced sunburn prevalence in a population at high risk of melanoma. Eur. J. Cancer Prev. 2, 447–456 (1993).
  • Diffey B. Has the sun protection factor had its day? Br. Med. J. 320, 176–177 (2000).
  • Autier P, Boniol M, Severi G et al. Quantity of sunscreens used by European students. Br. J. Dermatol. 144, 288–291 (2001).
  • McCarthy WH. The Australian experience in sun protection and screening for melanoma. J. Surg. Oncol. 86, 236–245 (2004).
  • Gerber B, Mathys P, Moser M et al. Ultraviolet emission spectra of sunbeds. Photochem. Photobiol. 76, 664–668 (2002).
  • Miller SA, Hamilton SL, Wester UG et al. An analysis of UVA emissions from sunlamps and the potential importance for melanoma. Photochem. Photobiol. 68, 63–70 (1998).
  • Autier P, Joarlette M, Lejeune F et al. Cutaneous malignant melanoma and exposure to sunlamps and sunbeds: a descriptive study in Belgium. Melanoma Res. 1, 69–74 (1991).
  • Westerdahl J, Olsson H, Masbäck A et al. Use of sunbeds or sunlamps and malignant melanoma in Southern Sweden. Am. J. Epidemiol. 140, 691–699 (1994).
  • Autier P, Doré JF, Lejeune F et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: an EORTC multicenter case-control study in Belgium, France and Germany. Int. J. Cancer 58, 809–813 (1994).
  • Westerdahl J, Ingvar C, Masback A et al. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UVA carcinogenicity. Br. J. Cancer 82, 1593–1599 (2000).
  • Chen Y, Dubrow R, Zheng T et al. Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int. J. Epidemiol. 27, 758–765 (1998).
  • Gallagher RP, Spinelli JJ, Lee TK et al. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14, 562–566 (2005).
  • Veierød MB, Weiderpasss E, Lund E et al. Re: prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J. Natl Cancer Inst. 96, 337–338 (2004).
  • Swerdlow AJ, English JSC, MacKie RM et al. Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. Br. Med. J. 297, 647–650 (1988).
  • Walter SD, Marrett LD, From L et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am. J. Epidemiol. 131, 232–243 (1990).
  • Veierød MB, Weiderpasss E, Lund E et al. Re: prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J. Natl Cancer Inst. 96, 337–338 (2004).
  • Black G, Matzinger E, Gange RW et al. Lack of photoprotection against UVB-induced erythema by immediate pigmentation induced by 382 nm radiation. J. Invest. Dermatol. 85, 448–449 (1985).
  • Young AR. Tanning devices – fast track to skin cancer? Pigment Cell Res. 17, 2–9 (2004).
  • Gange RW, Blackett AD, Matzinger EA et al. Comparative protection efficiency of UVA- and UVB-induced tans against erythema and formation of endonuclease-sensitive sites in DNA by UVB in human skin. J. Invest. Dermatol. 85, 362–364 (1985).
  • Rivers JK, Norris PG, Murphy GM et al. UVA sunbeds: tanning, photoprotection, acute adverse effects and immunological changes. Br. J. Dermatol. 120, 767–777 (1989).
  • Seehan JM, Potten CS, Young AR et al. Tanning in human skin types II and III offers modest photoprotection against erythema. Photochem. Photobiol. 68, 588–592 (1998).
  • Hemminki K, Bykov VJ, Marcuson JA et al. Re: Sunscreen use and duration of sun exposure: A double-blind, randomised trial. J. Natl Cancer Inst. 91, 2016–2047 (1999).
  • Bykov VJ, Marcusson JA, Hemminki K et al. Protective effects of tanning on cutaneous melanoma. Dermatology 202, 22–26 (2004).
  • Ruegemer J, Schuetz B, Hermann K et al. UV-induced skin changes due to regular use of commercial sunbeds. Photodermatol. Photoimmunol. Photomed. 18, 223–227 (2002).
  • Woollons A, Clingen PH, Price ML et al. Induction of mutagenic damage in human fibroblasts after exposure to artificial tanning lamps. Br. J. Dermatol. 137, 687–692 (1997).
  • Whitmore SE, Morison WL, Potten CS et al. Tanning salon exposure and molecular alterations. J. Am. Acad. Dermatol. 44(5), 775–780 (2001).
  • Persson AE, Edstrom DW, Backvall H et al. The mutagenic effect of ultraviolet-A1 on human skin demonstrated by sequencing the p53 gene in single keratinocytes. Photodermatol. Photoimmunol. Photomed. 18, 287–293 (2002).
  • Boldeman C, Jansson B, Nilsson B et al. Sunbed use in Swedish urban adolescents related to behavioral characteristics. Prev. Med. 26, 114–119 (1997).
  • Hamlet N, Kennedy K. Reconnaissance study of sunbed use by primary school children in Lanarkshire. Eur. J. Public Health 26, 31–33 (2004).
  • Paul CL, Girgis A, Tzelepis F et al. Solaria use by minors in Australia: is there a cause for concern? Aust. NZ J. Public Health28, 90 (2004).
  • Dellavalle RP, Parker ER, Cersonsky N et al. Youth access laws: in the dark at the tanning parlor. Arch. Dermatol.139, 443–448 (2003).
  • Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16, 83–95 (2005).
  • Lim HW. Sunlight, tanning booths, and vitamin D. J. Am. Acad. Dermatol. 52, 868–876 (2005).
  • Agar NS, Halliday GM, Barnetson RStC et al. The basal layer in human squamous tumours harbors more UVA than UVB fingerprints mutations: A role for UVA in human skin carcinogenesis. Proc. Natl Acad. Sci. USA 101, 4954–4959 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.